$2.98 Billion is the total value of BRAIDWELL LP's 90 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | GUARDANT HEALTH INCnote 11/1 | $156,738,792 | – | 250,022,000 | +100.0% | 5.25% | – | |
| New | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $118,195,691 | – | 145,520,000 | +100.0% | 3.96% | – | |
| New | NOVOCURE LTDnote 11/0 | $117,582,745 | – | 131,834,000 | +100.0% | 3.94% | – | |
| New | EXACT SCIENCES CORPnote 0.375% 3/0 | $109,643,200 | – | 139,000,000 | +100.0% | 3.67% | – | |
| New | ALPHATEC HLDGS INCnote 0.750% 8/0 | $103,135,300 | – | 112,250,000 | +100.0% | 3.46% | – | |
| New | NEVRO CORPnote 2.750% 4/0 | $100,237,793 | – | 109,251,000 | +100.0% | 3.36% | – | |
| GKOS | New | GLAUKOS CORP | $72,589,652 | – | 1,661,851 | +100.0% | 2.43% | – |
| ISEE | New | IVERIC BIO INC | $71,537,233 | – | 3,341,300 | +100.0% | 2.40% | – |
| BIIB | New | BIOGEN INC | $69,933,931 | – | 252,542 | +100.0% | 2.34% | – |
| PCVX | New | VAXCYTE INC | $65,321,230 | – | 1,362,278 | +100.0% | 2.19% | – |
| NTRA | New | NATERA INC | $65,116,052 | – | 1,621,012 | +100.0% | 2.18% | – |
| New | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $63,675,000 | – | 141,500,000 | +100.0% | 2.13% | – | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $63,495,034 | – | 3,469,674 | +100.0% | 2.13% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $61,041,977 | – | 1,548,110 | +100.0% | 2.05% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $59,204,892 | – | 223,120 | +100.0% | 1.98% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $53,620,098 | – | 3,271,513 | +100.0% | 1.80% | – |
| New | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $49,369,841 | – | 65,976,000 | +100.0% | 1.65% | – | |
| New | IONIS PHARMACEUTICALS INCnote 4/0 | $48,949,313 | – | 52,740,000 | +100.0% | 1.64% | – | |
| NVRO | New | NEVRO CORP | $47,215,001 | – | 1,192,298 | +100.0% | 1.58% | – |
| New | TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $46,649,782 | – | 50,536,000 | +100.0% | 1.56% | – | |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $46,616,468 | – | 497,667 | +100.0% | 1.56% | – |
| ALGN | New | ALIGN TECHNOLOGY INC | $46,383,237 | – | 219,930 | +100.0% | 1.55% | – |
| OM | New | OUTSET MED INC | $44,011,533 | – | 1,704,552 | +100.0% | 1.48% | – |
| New | AMYRIS INCnote 1.500%11/1 | $43,250,438 | – | 137,850,000 | +100.0% | 1.45% | – | |
| KIDS | New | ORTHOPEDIATRICS CORP | $41,505,891 | – | 1,044,699 | +100.0% | 1.39% | – |
| New | EXACT SCIENCES CORPnote 0.375% 3/1 | $40,089,000 | – | 48,300,000 | +100.0% | 1.34% | – | |
| ACRS | New | ACLARIS THERAPEUTICS INC | $37,705,264 | – | 2,393,985 | +100.0% | 1.26% | – |
| New | INSMED INCnote 1.750% 1/1 | $37,665,128 | – | 399,630,000 | +100.0% | 1.26% | – | |
| New | NEOGENOMICS INCnote 1.250% 5/0 | $36,469,375 | – | 43,000,000 | +100.0% | 1.22% | – | |
| PEN | New | PENUMBRA INC | $36,222,717 | – | 162,828 | +100.0% | 1.21% | – |
| AMGN | New | AMGEN INC | $34,432,104 | – | 131,100 | +100.0% | 1.15% | – |
| BLU | New | BELLUS HEALTH INC NEW | $33,804,701 | – | 4,112,494 | +100.0% | 1.13% | – |
| New | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $33,358,282 | – | 36,533,000 | +100.0% | 1.12% | – | |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $32,852,402 | – | 658,101 | +100.0% | 1.10% | – |
| New | NUVASIVE INCnote 0.375% 3/1 | $32,210,203 | – | 36,665,000 | +100.0% | 1.08% | – | |
| New | NEOGENOMICS INCnote 0.250% 1/1 | $31,947,371 | – | 48,678,000 | +100.0% | 1.07% | – | |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $31,629,311 | – | 1,242,802 | +100.0% | 1.06% | – |
| MRUS | New | MERUS N V | $30,910,360 | – | 1,998,084 | +100.0% | 1.04% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $30,610,953 | – | 1,455,585 | +100.0% | 1.03% | – |
| New | TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $28,685,250 | – | 31,350,000 | +100.0% | 0.96% | – | |
| KRYS | New | KRYSTAL BIOTECH INC | $28,365,196 | – | 358,056 | +100.0% | 0.95% | – |
| New | HILLEVAX INC | $27,106,214 | – | 1,620,216 | +100.0% | 0.91% | – | |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $26,825,519 | – | 1,246,539 | +100.0% | 0.90% | – |
| New | DICE THERAPEUTICS INC | $26,179,140 | – | 839,075 | +100.0% | 0.88% | – | |
| New | QUIDELORTHO CORP | $25,738,438 | – | 300,437 | +100.0% | 0.86% | – | |
| GMED | New | GLOBUS MED INCcl a | $25,521,103 | – | 343,626 | +100.0% | 0.86% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $23,770,486 | – | 1,493,121 | +100.0% | 0.80% | – |
| ANAB | New | ANAPTYSBIO INC | $22,502,521 | – | 726,122 | +100.0% | 0.75% | – |
| SILK | New | SILK RD MED INC | $22,028,779 | – | 416,817 | +100.0% | 0.74% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $21,140,913 | – | 3,393,405 | +100.0% | 0.71% | – |
| New | BIOMARIN PHARMACEUTICAL INCnote 1.250% 5/1 | $20,727,568 | – | 19,200,000 | +100.0% | 0.70% | – | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $20,146,009 | – | 389,596 | +100.0% | 0.68% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $19,800,000 | – | 1,000,000 | +100.0% | 0.66% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $18,740,216 | – | 413,600 | +100.0% | 0.63% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $18,712,578 | – | 303,185 | +100.0% | 0.63% | – |
| ARGX | New | ARGENX SEsponsored adr | $18,638,436 | – | 49,200 | +100.0% | 0.62% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $18,524,911 | – | 12,107,785 | +100.0% | 0.62% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $18,186,812 | – | 140,352 | +100.0% | 0.61% | – |
| REPL | New | REPLIMUNE GROUP INC | $18,015,893 | – | 662,349 | +100.0% | 0.60% | – |
| STE | New | STERIS PLC | $17,673,725 | – | 95,694 | +100.0% | 0.59% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $17,557,151 | – | 235,319 | +100.0% | 0.59% | – |
| IMGN | New | IMMUNOGEN INC | $17,233,505 | – | 3,474,497 | +100.0% | 0.58% | – |
| COO | New | COOPER COS INC | $17,232,867 | – | 52,115 | +100.0% | 0.58% | – |
| New | INVITAE CORPnote 2.000% 9/0 | $17,038,830 | – | 21,500,000 | +100.0% | 0.57% | – | |
| New | NUVASIVE INCnote 1.000% 6/0 | $16,231,875 | – | 16,500,000 | +100.0% | 0.54% | – | |
| New | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $16,151,021 | – | 42,294,000 | +100.0% | 0.54% | – | |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $15,157,984 | – | 325,838 | +100.0% | 0.51% | – |
| LUNG | New | PULMONX CORP | $13,669,194 | – | 1,621,494 | +100.0% | 0.46% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $10,915,422 | – | 1,862,700 | +100.0% | 0.37% | – |
| IMTX | New | IMMATICS N.V | $10,887,953 | – | 1,250,052 | +100.0% | 0.36% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $10,122,298 | – | 927,800 | +100.0% | 0.34% | – |
| New | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $9,574,200 | – | 9,000,000 | +100.0% | 0.32% | – | |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $9,154,502 | – | 313,403 | +100.0% | 0.31% | – |
| CMPX | New | COMPASS THERAPEUTICS INC | $9,125,758 | – | 1,814,266 | +100.0% | 0.31% | – |
| NKTX | New | NKARTA INC | $9,139,542 | – | 1,525,800 | +100.0% | 0.31% | – |
| DYN | New | DYNE THERAPEUTICS INC | $8,728,951 | – | 753,145 | +100.0% | 0.29% | – |
| New | INSMED INCnote 0.750% 6/0 | $8,300,000 | – | 10,000,000 | +100.0% | 0.28% | – | |
| NUVB | New | NUVATION BIO INC | $7,915,968 | – | 4,122,900 | +100.0% | 0.26% | – |
| ALLK | New | ALLAKOS INC | $7,748,960 | – | 920,304 | +100.0% | 0.26% | – |
| ALEC | New | ALECTOR INC | $6,691,972 | – | 725,024 | +100.0% | 0.22% | – |
| KOD | New | KODIAK SCIENCES INC | $6,545,736 | – | 914,209 | +100.0% | 0.22% | – |
| New | SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $6,418,750 | – | 6,500,000 | +100.0% | 0.22% | – | |
| FUSN | New | FUSION PHARMACEUTICALS INC | $6,300,000 | – | 2,000,000 | +100.0% | 0.21% | – |
| MIST | New | MILESTONE PHARMACEUTICALS IN | $4,612,802 | – | 1,164,849 | +100.0% | 0.16% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $4,001,760 | – | 381,120 | +100.0% | 0.13% | – | |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $2,910,816 | – | 258,280 | +100.0% | 0.10% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $1,401,833 | – | 620,280 | +100.0% | 0.05% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $1,398,055 | – | 71,585 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 4 | Q3 2023 | 6.3% |
| EXACT SCIENCES CORP | 4 | Q3 2023 | 4.4% |
| NOVOCURE LTD | 4 | Q3 2023 | 3.9% |
| NANOSTRING TECHNOLOGIES INC | 4 | Q3 2023 | 4.0% |
| NEVRO CORP | 4 | Q3 2023 | 3.4% |
| BRIDGEBIO PHARMA INC | 4 | Q3 2023 | 3.5% |
| ALPHATEC HLDGS INC | 4 | Q3 2023 | 3.6% |
| GLAUKOS CORP | 4 | Q3 2023 | 3.0% |
| VAXCYTE INC | 4 | Q3 2023 | 2.8% |
| XENON PHARMACEUTICALS INC | 4 | Q3 2023 | 2.5% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.